Published in Antimicrob Agents Chemother on March 01, 2004
Drug resistance in leishmaniasis. J Glob Infect Dis (2010) 1.52
Possible mechanism of miltefosine-mediated death of Leishmania donovani. Antimicrob Agents Chemother (2004) 1.46
Targeting essential pathways in trypanosomatids gives insights into protozoan mechanisms of cell death. Parasit Vectors (2010) 1.22
Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it? Int J Parasitol Drugs Drug Resist (2012) 1.20
Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions. Antimicrob Agents Chemother (2005) 1.18
Miltefosine in the treatment of leishmaniasis: Clinical evidence for informed clinical risk management. Ther Clin Risk Manag (2007) 1.17
Cooperation between apoptotic and viable metacyclics enhances the pathogenesis of Leishmaniasis. PLoS One (2009) 1.17
Apoptotic markers in protozoan parasites. Parasit Vectors (2010) 1.16
Processing of metacaspase into a cytoplasmic catalytic domain mediating cell death in Leishmania major. Mol Microbiol (2010) 1.11
Tolerance to drug-induced cell death favours the acquisition of multidrug resistance in Leishmania. Cell Death Dis (2011) 1.08
Leishmania promastigotes lack phosphatidylserine but bind annexin V upon permeabilization or miltefosine treatment. PLoS One (2012) 1.06
Antimicrobial peptide-induced apoptotic death of leishmania results from calcium-de pend ent, caspase-independent mitochondrial toxicity. J Biol Chem (2009) 1.06
Multiple mutations in heterogeneous miltefosine-resistant Leishmania major population as determined by whole genome sequencing. PLoS Negl Trop Dis (2012) 1.06
Miltefosine-induced apoptotic cell death on Leishmania major and L. tropica strains. Korean J Parasitol (2011) 1.01
Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in Leishmania donovani promastigotes. Antimicrob Agents Chemother (2007) 0.94
Cathepsin B-like and cell death in the unicellular human pathogen Leishmania. Cell Death Dis (2010) 0.93
In vitro bactericidal activity of the antiprotozoal drug miltefosine against Streptococcus pneumoniae and other pathogenic streptococci. Antimicrob Agents Chemother (2007) 0.90
Leishmania mexicana metacaspase is a negative regulator of amastigote proliferation in mammalian cells. Cell Death Dis (2012) 0.90
Activity of the julocrotine, a glutarimide alkaloid from Croton pullei var. glabrior, on Leishmania (L.) amazonensis. Parasitol Res (2010) 0.90
In vitro and in vivo activity of Aloe vera leaf exudate in experimental visceral leishmaniasis. Parasitol Res (2008) 0.89
Mitochondrial disruption and DNA fragmentation in Trypanosoma cruzi induced by naphthoimidazoles synthesized from beta-lapachone. Parasitol Res (2007) 0.87
Programmed cell death in Leishmania: biochemical evidence and role in parasite infectivity. Front Cell Infect Microbiol (2012) 0.87
Effects of serine protease inhibitors on viability and morphology of Leishmania (Leishmania) amazonensis promastigotes. Parasitol Res (2007) 0.86
In vitro and in vivo efficacy of ether lipid edelfosine against Leishmania spp. and SbV-resistant parasites. PLoS Negl Trop Dis (2012) 0.85
The calpain inhibitor MDL28170 induces the expression of apoptotic markers in Leishmania amazonensis promastigotes. PLoS One (2014) 0.85
Antileishmanial activity of semisynthetic lupane triterpenoids betulin and betulinic acid derivatives: synergistic effects with miltefosine. PLoS One (2014) 0.84
Activities of naphthylisoquinoline alkaloids and synthetic analogs against Leishmania major. Antimicrob Agents Chemother (2006) 0.84
Imipramine is an orally active drug against both antimony sensitive and resistant Leishmania donovani clinical isolates in experimental infection. PLoS Negl Trop Dis (2012) 0.84
Aziridine-2,3-dicarboxylate-based cysteine cathepsin inhibitors induce cell death in Leishmania major associated with accumulation of debris in autophagy-related lysosome-like vacuoles. Antimicrob Agents Chemother (2010) 0.84
Induction of mitochondrial dysfunction and oxidative stress in Leishmania donovani by orally active clerodane diterpene. Antimicrob Agents Chemother (2014) 0.82
The Effects of N-Butyl-1-(4-dimethylamino)phenyl-1,2,3,4-tetrahydro- β -carboline-3-carboxamide against Leishmania amazonensis Are Mediated by Mitochondrial Dysfunction. Evid Based Complement Alternat Med (2013) 0.82
Novel features of a PIWI-like protein homolog in the parasitic protozoan Leishmania. PLoS One (2012) 0.82
Calpains: potential targets for alternative chemotherapeutic intervention against human pathogenic trypanosomatids. Curr Med Chem (2013) 0.82
Implication of different domains of the Leishmania major metacaspase in cell death and autophagy. Cell Death Dis (2015) 0.82
Leishmania mexicana amazonensis: plasma membrane adenine nucleotide translocator and chemotaxis. Exp Parasitol (2007) 0.82
Calpain research for drug discovery: challenges and potential. Nat Rev Drug Discov (2016) 0.82
Mitochondria Superoxide Anion Production Contributes to Geranylgeraniol-Induced Death in Leishmania amazonensis. Evid Based Complement Alternat Med (2012) 0.81
Drug Development Against the Major Diarrhea-Causing Parasites of the Small Intestine, Cryptosporidium and Giardia. Front Microbiol (2015) 0.80
Apoptosis-like programmed cell death induces antisense ribosomal RNA (rRNA) fragmentation and rRNA degradation in Leishmania. Cell Death Differ (2012) 0.80
Edelfosine induces an apoptotic process in Leishmania infantum that is regulated by the ectopic expression of Bcl-XL and Hrk. Antimicrob Agents Chemother (2008) 0.80
Enterocin AS-48 as Evidence for the Use of Bacteriocins as New Leishmanicidal Agents. Antimicrob Agents Chemother (2017) 0.80
Leishmanicidal activities of Artemisia annua leaf essential oil against Visceral Leishmaniasis. Front Microbiol (2014) 0.79
Therapeutic switching in leishmania chemotherapy: a distinct approach towards unsatisfied treatment needs. J Parasit Dis (2011) 0.79
Molecular Chaperones of Leishmania: Central Players in Many Stress-Related and -Unrelated Physiological Processes. Biomed Res Int (2015) 0.78
Characterization of Leishmania major phosphatidylethanolamine methyltransferases LmjPEM1 and LmjPEM2 and their inhibition by choline analogs. Mol Biochem Parasitol (2014) 0.78
Miltefosine increases lipid and protein dynamics in Leishmania amazonensis membranes at concentrations similar to those needed for cytotoxicity activity. Antimicrob Agents Chemother (2014) 0.78
Oral azithromycin versus its combination with miltefosine for the treatment of experimental Old World cutaneous leishmaniasis. J Parasit Dis (2014) 0.77
16alpha-Hydroxycleroda-3,13 (14)Z-dien-15,16-olide from Polyalthia longifolia: a safe and orally active antileishmanial agent. Br J Pharmacol (2010) 0.77
A Telomeric Cluster of Antimony Resistance Genes on Chromosome 34 of Leishmania infantum. Antimicrob Agents Chemother (2016) 0.77
Deprivation of L-Arginine Induces Oxidative Stress Mediated Apoptosis in Leishmania donovani Promastigotes: Contribution of the Polyamine Pathway. PLoS Negl Trop Dis (2016) 0.76
Apoptosis-like cell death in Leishmania donovani treated with KalsomeTM10, a new liposomal amphotericin B. PLoS One (2017) 0.75
Mitochondrial Proteomics of Antimony and Miltefosine Resistant Leishmania infantum. Proteomes (2015) 0.75
Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress. PLoS Negl Trop Dis (2017) 0.75
Biological Activity of Coumarin Derivatives as Anti-Leishmanial Agents. PLoS One (2016) 0.75
Metacaspase-binding peptide inhibits heat shock-induced death in Leishmania (L.) amazonensis. Cell Death Dis (2017) 0.75
Methionine aminopeptidase 2 is a key regulator of apoptotic like cell death in Leishmania donovani. Sci Rep (2017) 0.75
β-Nitrostyrenes as Potential Anti-leishmanial Agents. Front Microbiol (2016) 0.75
Himatanthus Willd. ex Schult. (Apocynaceae): Review. Pharmacogn Rev (2016) 0.75
Tamoxifen Induces Apoptosis of Leishmania major Promastigotes in Vitro. Korean J Parasitol (2016) 0.75
New Approaches to Overcome Transport Related Drug Resistance in Trypanosomatid Parasites. Front Pharmacol (2016) 0.75
Caspases: enemies within. Science (1998) 19.45
Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (1980) 17.69
A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods (1991) 16.64
A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods (1995) 16.00
Social controls on cell survival and cell death. Nature (1992) 9.81
A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature (1998) 8.93
Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis (2002) 7.17
Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N Engl J Med (1999) 5.02
Leishmaniasis. Public health aspects and control. Clin Dermatol (1997) 4.77
Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell (2000) 4.19
Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem (1998) 3.80
Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health (2001) 3.08
On the origin, evolution, and nature of programmed cell death: a timeline of four billion years. Cell Death Differ (2002) 2.50
Programmed cell death in the unicellular protozoan parasite Leishmania. Cell Death Differ (2002) 2.05
Apoptotic molecular machinery: vastly increased complexity in vertebrates revealed by genome comparisons. Science (2001) 1.97
On the evolution of programmed cell death: apoptosis of the unicellular eukaryote Leishmania major involves cysteine proteinase activation and mitochondrion permeabilization. Cell Death Differ (2002) 1.90
Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine). Int J Antimicrob Agents (2003) 1.83
Programmed cell death in Dictyostelium. J Cell Sci (1994) 1.73
Cell death in Leishmania induced by stress and differentiation: programmed cell death or necrosis? Cell Death Differ (2002) 1.70
Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B. Acta Trop (2002) 1.64
Trial of oral miltefosine for visceral leishmaniasis. Lancet (1998) 1.58
Hydrogen peroxide induces apoptosis-like death in Leishmania donovani promastigotes. J Cell Sci (2001) 1.54
Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent. Clin Infect Dis (2001) 1.41
Programmed cell death of the dinoflagellate Peridinium gatunense is mediated by CO(2) limitation and oxidative stress. Curr Biol (1999) 1.39
The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei. J Antimicrob Chemother (1996) 1.37
Apoptosis in a unicellular eukaryote (Trypanosoma cruzi): implications for the evolutionary origin and role of programmed cell death in the control of cell proliferation, differentiation and survival. Cell Death Differ (1995) 1.37
Antimonial-mediated DNA fragmentation in Leishmania infantum amastigotes. Antimicrob Agents Chemother (2001) 1.34
Short-course of oral miltefosine for treatment of visceral leishmaniasis. Clin Infect Dis (2000) 1.29
Clan CD cysteine peptidases of parasitic protozoa. Trends Parasitol (2003) 1.28
Cytotoxic activities of alkylphosphocholines against clinical isolates of Acanthamoeba spp. Antimicrob Agents Chemother (2002) 1.28
Noncaspase proteases in apoptosis. Leukemia (2000) 1.27
A metacaspase of Trypanosoma brucei causes loss of respiration competence and clonal death in the yeast Saccharomyces cerevisiae. FEBS Lett (2002) 1.24
Ether--lipid (alkyl-phospholipid) metabolism and the mechanism of action of ether--lipid analogues in Leishmania. Mol Biochem Parasitol (2000) 1.23
Heat shock induction of apoptosis in promastigotes of the unicellular organism Leishmania (Leishmania) amazonensis. J Cell Physiol (1996) 1.21
Nitric oxide-mediated proteasome-dependent oligonucleosomal DNA fragmentation in Leishmania amazonensis amastigotes. Infect Immun (2002) 1.19
Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis. Cancer Res (1999) 1.18
Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice. Antimicrob Agents Chemother (2001) 1.16
The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani. Biochem Pharmacol (1987) 1.15
Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice. Antimicrob Agents Chemother (1992) 1.15
Oral treatment of visceral leishmaniasis with miltefosine. Ann Trop Med Parasitol (1999) 1.13
Programmed nuclear death: apoptotic-like degradation of specific nuclei in conjugating Tetrahymena. Dev Biol (1992) 1.11
Induction of ceramide-mediated apoptosis by the anticancer phospholipid analog, hexadecylphosphocholine. J Biol Chem (1998) 1.06
Effects of miltefosine and other alkylphosphocholines on human intestinal parasite Entamoeba histolytica. Antimicrob Agents Chemother (2001) 1.05
Effect of the alkyl-lysophospholipids on the proliferation and differentiation of Trypanosoma cruzi. Acta Trop (2000) 1.03
Reactive oxygen species activate a Ca2+-dependent cell death pathway in the unicellular organism Trypanosoma brucei brucei. Biochem J (1999) 1.01
Short- and long-term efficacy of hexadecylphosphocholine against established Leishmania infantum infection in BALB/c mice. Antimicrob Agents Chemother (1998) 1.00
Mechanism of action of anti-proliferative lysophospholipid analogues against the protozoan parasite Trypanosoma cruzi: potentiation of in vitro activity by the sterol biosynthesis inhibitor ketoconazole. J Antimicrob Chemother (2001) 1.00
Leishmaniasis in HIV infection. J Postgrad Med (2003) 1.00
Hexadecylphosphocholine inhibits translocation of CTP:choline-phosphate cytidylyltransferase in Madin-Darby canine kidney cells. J Biol Chem (1992) 0.99
The antiproliferative effect of hexadecylphosphocholine toward HL60 cells is prevented by exogenous lysophosphatidylcholine. Biochim Biophys Acta (1998) 0.98
Characterization and role of protozoan parasite proteasomes. Trends Parasitol (2003) 0.96
Ether lipid metabolism, GPI anchor biosynthesis, and signal transduction are putative targets for anti-leishmanial alkyl phospholipid analogues. Adv Exp Med Biol (1996) 0.95
Effects of miltefosine on various biochemical parameters in a panel of tumor cell lines with different sensitivities. Biochem Pharmacol (2001) 0.93
The phospholipid analogue hexadecylphosphocholine inhibits phosphatidylcholine biosynthesis in Madin-Darby canine kidney cells. FEBS Lett (1991) 0.93
Alkyl-lysophospholipids as anticancer agents and enhancers of radiation-induced apoptosis. Int J Radiat Oncol Biol Phys (2001) 0.93
Programmed cell death in procyclic form Trypanosoma brucei rhodesiense --identification of differentially expressed genes during con A induced death. Mem Inst Oswaldo Cruz (1999) 0.91
Accumulation of an alkyl lysophospholipid in tumor cell membranes affects membrane fluidity and tumor cell invasion. Lipids (1987) 0.90
Early stage monitoring of miltefosine induced apoptosis in KB cells by multinuclear NMR spectroscopy. Anticancer Res (1996) 0.90
Proinflammatory and cytotoxic effects of hexadecylphosphocholine (miltefosine) against drug-resistant strains of Trypanosoma cruzi. Antimicrob Agents Chemother (2002) 0.89
Changes of intracellular calcium, fatty acids and phospholipids during miltefosine-induced apoptosis monitored by fluorescence- and 13C NMR-spectroscopy. Anticancer Res (2000) 0.86
A DEVD-inhibited caspase other than CPP32 is involved in the commitment of cerebellar granule neurons to apoptosis induced by K+ deprivation. J Neurochem (1998) 0.85
Uptake, subcellular distribution and metabolism of the phospholipid analogue hexadecylphosphocholine in MDCK cells. Biochim Biophys Acta (1994) 0.84
Efficacy of anticancer alkylphosphocholines in Trypanosoma brucei subspecies. Acta Trop (1997) 0.82
Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients. Cancer Treat Rev (1990) 0.82
The interference effects of hexadecylphosphocholine on proliferation and membrane phospholipid metabolism in human myeloid leukemia cell lines. Int J Tissue React (1998) 0.81
Antiparasitic activity of some New Caledonian medicinal plants. J Ethnopharmacol (2007) 1.24
Cytochrome b gene quantitative PCR for diagnosing Plasmodium falciparum infection in travelers. J Clin Microbiol (2011) 1.10
Leishmania resistance to miltefosine associated with genetic marker. Emerg Infect Dis (2012) 1.07
Composition, and antimicrobial and remarkable antiprotozoal activities of the essential oil of rhizomes of Aframomum sceptrum K. Schum. (Zingiberaceae). Chem Biodivers (2011) 1.07
Cloning of S-adenosyl-L-methionine:C-24-Delta-sterol-methyltransferase (ERG6) from Leishmania donovani and characterization of mRNAs in wild-type and amphotericin B-Resistant promastigotes. Antimicrob Agents Chemother (2004) 1.04
Interaction of sitamaquine with membrane lipids of Leishmania donovani promastigotes. Biochim Biophys Acta (2006) 1.04
Practical and efficient synthesis of pyrano[3,2-c]pyridone, pyrano[4,3-b]pyran and their hybrids with nucleoside as potential antiviral and antileishmanial agents. Bioorg Med Chem Lett (2010) 1.01
Synthesis and antikinetoplastid activities of 3-substituted quinolinones derivatives. Eur J Med Chem (2012) 0.99
Selection of the most promising 2-substituted quinoline as antileishmanial candidate for clinical trials. Biomed Pharmacother (2008) 0.99
Hexadecylphosphocholine interaction with lipid monolayers. Biochim Biophys Acta (2004) 0.98
Retracted Mechanisms of drug action and drug resistance in Leishmania as basis for therapeutic target identification and design of antileishmanial modulators. Curr Top Med Chem (2006) 0.97
Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases. Antimicrob Agents Chemother (2005) 0.97
Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin B. Antimicrob Agents Chemother (2003) 0.97
Cystic dystrophy of the duodenal wall associated with chronic alcoholic pancreatitis. Clinical features, diagnostic procedures and therapeutic management in a retrospective multicenter series of 23 patients. Gastroenterol Clin Biol (2006) 0.96
Bioactive properties of plant species ingested by chimpanzees (Pan troglodytes schweinfurthii) in the Kibale National Park, Uganda. Am J Primatol (2006) 0.93
Efficacy and pharmacokinetics of intravenous nanocapsule formulations of halofantrine in Plasmodium berghei-infected mice. Antimicrob Agents Chemother (2004) 0.88
Prevalence of hepatitis C infection and risk factors in hospitalized diabetic patients: results of a cross-sectional study. Eur J Gastroenterol Hepatol (2008) 0.87
Leishmania major and HIV co-infection in Burkina Faso. Trans R Soc Trop Med Hyg (2003) 0.87
Synthesis of oxysterols and nitrogenous sterols with antileishmanial and trypanocidal activities. Eur J Med Chem (2006) 0.85
Antileishmanial and trypanocidal activity of Brazilian Cerrado plants. Mem Inst Oswaldo Cruz (2005) 0.84
Ionic liquid mediated and promoted eco-friendly preparation of thiazolidinone and pyrimidine nucleoside-thiazolidinone hybrids and their antiparasitic activities. Bioorg Med Chem Lett (2009) 0.84
Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives. Bioorg Chem (2005) 0.83
Interaction between miltefosine and amphotericin B: consequences for their activities towards intestinal epithelial cells and Leishmania donovani promastigotes in vitro. Antimicrob Agents Chemother (2006) 0.82
Selection and phenotype characterisation of sitamaquine-resistant promastigotes of Leishmania donovani. Biomed Pharmacother (2008) 0.82
Drug-free chitosan coated poly(isobutylcyanoacrylate) nanoparticles are active against trichomonas vaginalis and non-toxic towards pig vaginal mucosa. Pharm Res (2014) 0.81
In vitro antileishmanial activity of fluoro-artemisinin derivatives against Leishmania donovani. Biomed Pharmacother (2008) 0.80
Hydroperoxy-cycloartane triterpenoids from the leaves of Markhamia lutea, a plant ingested by wild chimpanzees. Phytochemistry (2009) 0.80
The Ugi reaction in the generation of new nucleosides as potential antiviral and antileishmanial agents. Bioorg Chem (2006) 0.79
Antimalarial activity of axidjiferosides, new β-galactosylceramides from the African sponge Axinyssa djiferi. Mar Drugs (2013) 0.79
Aerosolized liposomal amphotericin B: prediction of lung deposition, in vitro uptake and cytotoxicity. Int J Pharm (2012) 0.78
Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines. Bioorg Med Chem Lett (2005) 0.78
Synthesis and anti-leishmanial activity of 1-aryl-β-carboline derivatives against Leishmania donovani. Bioorg Med Chem Lett (2012) 0.77
Klaivanolide, an antiprotozoal lactone from Uvaria klaineana. Phytochemistry (2002) 0.77
Synthesis of novel guttiferone A derivatives: in-vitro evaluation toward Plasmodium falciparum, Trypanosoma brucei and Leishmania donovani. Eur J Med Chem (2013) 0.76
Antileishmanial 2-substituted quinolines: in vitro behaviour towards biological components. Biomed Pharmacother (2007) 0.76
Structurally diverse 5-substituted pyrimidine nucleosides as inhibitors of Leishmania donovani promastigotes in vitro. Bioorg Med Chem Lett (2006) 0.76
Membrane lipidomics for the discovery of new antiparasitic drug targets. Trends Parasitol (2011) 0.76
"Squalenoylcurcumin" nanoassemblies as water-dispersible drug candidates with antileishmanial activity. ChemMedChem (2014) 0.76
In-vitro antileishmanial and trypanocidal activities of arsonoliposomes and preliminary in-vivo distribution in BALB/c mice. J Pharm Pharmacol (2003) 0.76
Solvent-free synthesis of pyrimidine nucleoside-aminophosphonate hybrids and their biological activity evaluation. Nucleosides Nucleotides Nucleic Acids (2010) 0.76
Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies. Int J Pharm (2013) 0.75
The unexpected increase of clotrimazole apparent solubility using randomly methylated β-cyclodextrin. J Mol Recognit (2015) 0.75
Comparison of electrospray ionization, atmospheric pressure chemical ionization and atmospheric pressure photoionization for a lipidomic analysis of Leishmania donovani. J Chromatogr A (2012) 0.75
Trypanocidal activity of arsonoliposomes: effect of vesicle lipid composition. Biomed Pharmacother (2007) 0.75
Adsorption of antisense oligonucleotides targeting malarial topoisomerase II on cationic nanoemulsions optimized by a full factorial design. Curr Top Med Chem (2014) 0.75
Acaricidal activity of tonka bean extracts. Synthesis and structure-activity relationships of bioactive derivatives. J Nat Prod (2003) 0.75
Pyrone and unusually furanone-substituted flavones from the leaves of Hoslundia opposita. Planta Med (2012) 0.75
New anti-malarial drugs: who cares? Curr Top Med Chem (2014) 0.75
Synthesis and antiprotozoal activity of original porphyrin precursors and derivatives. Eur J Med Chem (2013) 0.75
Antifungal and anthelmintic activities of Cleistopholis patens (Annonaceae). Planta Med (2009) 0.75
Perspectives for parasitology and parasitology networks in Europe. Trends Parasitol (2009) 0.75